CALCULATE YOUR SIP RETURNS

HRS Aluglaze Shares List at 31% Premium on BSE SME Platform

Written by: Neha DubeyUpdated on: 18 Dec 2025, 4:11 pm IST
HRS Aluglaze shares debuted on the BSE SME platform at ₹126, marking a 31% premium over the IPO issue price of ₹96 per share.
HRS Aluglaze Shares
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

HRS Aluglaze Limited made its stock market debut on 18 December, with its shares listing at a notable premium on the BSE SME platform. 

The listing followed a strongly subscribed initial public offering earlier this month. 

The company had raised funds through a fresh issue of shares and outlined specific plans for the utilisation of the proceeds.

Listing Performance on BSE SME

Shares of HRS Aluglaze were listed at ₹126 apiece on the BSE SME exchange. This represented a premium of over 31% compared with the issue price of ₹96 per share, indicating positive investor response on the day of listing.

Key Details of the HRS Aluglaze IPO

The company launched its IPO to raise ₹50.92 crore through a fresh issue of more than 53 lakh equity shares. 

The price band for the issue was fixed between ₹94 and ₹96 per share. The public issue remained open for subscription from 11 December to 15 December and witnessed demand of nearly 45 times.

Investor Participation and Lot Size

Retail investors were required to apply through a demat account for a minimum of 2,400 shares, which amounted to an investment of over ₹2.3 lakh at the upper end of the price band. Applications could be submitted in multiples of 1,200 shares thereafter.

Use of IPO Proceeds

According to the company, the funds raised through the IPO will be used for capacity expansion, purchase of plant and machinery, execution of new projects, meeting working capital requirements, and for general corporate purposes.

Business Profile of HRS Aluglaze

HRS Aluglaze is engaged in the design, fabrication, and installation of aluminium façades, glazing systems, doors, windows, curtain walls, and associated metal works. 

The company undertakes projects for builders, corporate clients, and institutions, with most of its operations concentrated in and around Gujarat.

Read More: Nephrocare Health Share Price Jumps 4% From Issue Price on Listing Day.

Conclusion

The market debut of HRS Aluglaze reflects investor interest in SME offerings within the construction and infrastructure services segment. Going forward, the company’s performance will depend on its execution capabilities and utilisation of the funds raised through the public issue.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Published on: Dec 18, 2025, 10:37 AM IST

Neha Dubey

Neha Dubey is a Content Analyst with 3 years of experience in financial journalism, having written for a leading newswire agency and multiple newspapers. At Angel One, she creates daily content on finance and the economy. Neha holds a degree in Economics and a Master’s in Journalism.

Know More

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Join our 3.5 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 3.5 Cr+ happy customers